Skip to main content
logo
Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
149.52
+3.19 (2.18%)
At close: Oct 30, 2026, 4:00 PM EDT
149.55
+0.03 (0.02%)
After-hours: Oct 30, 2026, 7:59 PM EDT

Merck & Co. Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
18,08516,60716,28616,40017,27615,80615,52915,62416,65716,11215,77514,63015,96215,03514,48713,83014,95914,59315,90113,521
Revenue Growth
4.68%5.07%4.88%4.97%3.72%-1.90%-1.56%6.79%4.35%7.16%8.89%5.79%6.71%3.03%-8.89%2.28%13.72%27.99%49.63%23.50%
Gross Profit
14,72912,47912,41112,10513,53112,41412,14611,91712,76912,43312,35110,83511,73111,04310,5909,98711,07910,44410,5679,434
Operating Income
7,454-406,2875,3757,0495,9236,2218,0974,3646,3846,699-6546,0835,8825,1434,3295,1345,2105,8173,600
Net Income
5,065-1,335-4,2402,9635,7854,4275,0793,7433,1575,4554,762-1,2264,745-5,9752,8213,0173,2483,9444,3103,758
Earnings Per Share
2.04-0.54-1.721.192.321.762.011.481.242.141.87-0.481.86-2.351.111.181.281.551.701.48
EPS Growth
-12.02%---19.28%86.99%-17.76%7.49%--33.33%-68.47%-45.31%--34.71%-20.00%-28.89%154.12%35.91%-

Revenue by Segment
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Keytruda/Keytruda Qlex
8,6018,3668,0348,3728,1477,9567,2057,8367,4297,2706,9476,6086,3386,2715,7955,4505,4265,2524,8094,577
Gardasil/Gardasil 9
1,9951,1691,0691,0311,7491,1261,3271,5502,3062,4782,2491,8712,5852,4581,9721,4702,2941,6741,4601,528
Januvia/Janumet
3804295745016246237964874826296707878358648809131,1331,2331,2331,393
ProQuad/M-M-R II/Varivax
730592538619684609539594703617570545713582528526668578470509
Bridion
144497472499439461441449420455440429424502487441423426395436
Lynparza - Alliance
352365341389379370312365337317292315299310275292284275266268
Winrevair
69458852546736033628020014970----------
Lenvima - Alliance
287283256272258265258255251249255226260242232216202231227206
Animal Health
1,6761,7751,7911,5051,6151,6461,5881,3971,4871,4821,5111,2781,4001,4561,4911,2301,3711,4671,4821,261
Other Product
141721465250110303185227222258211299122275420625370312221
Other
3,0852,4712,5402,6932,9712,3042,4802,3062,8662,3232,5832,3602,8092,2282,5522,8722,5333,0875,2473,122
Revenue (Total)
18,08516,60716,28616,40017,27615,80615,52915,62416,65716,11215,77514,63015,96215,03514,48713,83014,95914,59315,90113,521

Cash & Debt
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Investments
7,1417,1415,70214,56518,2148,6229,22813,68914,59311,3545,6197,0938,7736,37810,38713,19211,24810,1298,9328,096
Total Debt
53,91153,91149,11750,53441,37435,40234,84438,27038,13137,78834,21936,26834,86736,91130,74731,98530,41831,66331,79434,631
Net Cash (Debt)
-46,770-46,770-43,415-35,969-23,160-26,780-25,616-24,581-23,538-26,434-28,600-29,175-26,094-30,533-20,360-18,793-19,170-21,534-22,862-26,535
Net Cash Growth
--------------------
Net Cash Per Share
-18.87-18.94-17.56-14.46-9.27-10.66-10.12-9.69-9.26-10.39-11.24-11.52-10.25-12.03-7.98-7.38-7.54-8.48-9.01-10.47

Cash Flow & CapEx
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Cash Flow
-5,3703,9182,8577,8223,2932,5003,4509,2915,6373,0902467,7173,7041,3394,4305,6024,3024,7615,031
Capital Expenditures
--893-991-1,033-987-764-1,328-937-783-791-861-989-902-965-1,007-1,149-1,126-1,129-984-1,208
Free Cash Flow
-4,4772,9271,8246,8352,5291,1722,5138,5084,8462,229-7436,8152,7393323,2814,4763,1733,7773,823
Free Cash Flow Growth
-77.03%149.74%-27.42%-19.66%-47.81%-47.42%-24.84%76.93%571.39%-52.26%-13.68%-91.21%-14.18%23.48%92.89%564.97%49.16%

Margins
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Gross Margin
81.44%75.14%76.21%73.81%78.32%78.54%78.22%76.27%76.66%77.17%78.30%74.06%73.49%73.45%73.10%72.21%74.06%71.57%66.45%69.77%
Operating Margin
41.22%-0.24%38.60%32.77%40.80%37.47%40.06%51.82%26.20%39.62%42.47%-4.47%38.11%39.12%35.50%31.30%34.32%35.70%36.58%26.63%
Pretax Margin
30.74%-4.11%-21.70%20.85%39.04%31.63%38.01%26.69%24.55%37.28%35.94%-13.98%35.21%-35.48%25.20%25.40%23.95%30.75%30.57%28.91%
Profit Margin
28.01%-8.04%-26.04%18.07%33.49%28.01%32.71%23.96%18.95%33.86%30.19%-8.38%29.73%-39.74%19.47%21.82%21.71%27.03%27.11%27.79%
FCF Margin
-26.96%17.97%11.12%39.56%16.00%7.55%16.08%51.08%30.08%14.13%-5.08%42.70%18.22%2.29%23.72%29.92%21.74%23.75%28.27%

Dividends
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Dividend Per Share
0.8500.8500.8500.8100.8100.8100.8100.7700.7700.7700.7700.7300.7300.7300.7300.6900.6900.6900.6900.650
Dividend Per Share Growth
4.94%4.94%4.94%5.20%5.20%5.20%5.20%5.48%5.48%5.48%5.48%5.80%5.80%5.80%5.80%6.15%6.15%6.15%6.15%6.56%
Dividend Yield
2.31%2.58%2.72%3.07%3.80%3.98%3.46%3.09%2.67%2.43%2.24%2.68%2.79%2.46%2.63%2.49%3.16%2.94%3.22%3.40%

Valuation
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
146.15--14.3111.0112.1213.0114.7023.7022.83144.92-56.69-20.7319.3814.3013.9114.6314.84
Forward PE
17.0220.9223.4712.189.168.8310.0011.0513.3113.9715.3517.4713.3315.7115.2415.4512.5113.1511.2310.97
P/FCF Ratio
-19.7621.0721.1416.0713.5013.3113.9119.4023.8530.27-19.8427.0423.9819.1314.3116.0116.1120.04
PS Ratio
5.324.774.524.023.263.133.553.924.565.025.444.604.405.024.674.753.704.033.843.98